Neurodermatitis and Memory loss

Summary:

Memory loss is found among people with Neurodermatitis, especially for people who are female, 60+ old.

The study analyzes which people have Memory loss with Neurodermatitis. It is created by eHealthMe based on reports of 30 people who have Neurodermatitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Neurodermatitis?

Neurodermatitis (a skin disorder characterized by long lasting itching and scratching) is found to be associated with 310 drugs and 276 conditions by eHealthMe. Check the latest studies of Neurodermatitis.

What is Memory loss?

Memory loss is found to be associated with 2,726 drugs and 4,378 conditions by eHealthMe. Check the latest studies of Memory loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

30 people who have Neurodermatitis and Memory Loss are studied.

Would you have Memory loss when you have Neurodermatitis?

Gender of people who have Neurodermatitis and experienced Memory Loss *:

female: 72.41 %
male: 27.59 %

Age of people who have Neurodermatitis and experienced Memory Loss *:

Common co-existing conditions for these people *:

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 16 people, 53.33%
Pain: 6 people, 20.00%
Neurological Symptom (symptoms of nervous system disease): 6 people, 20.00%
Neuralgia (pain in one or more nerves): 6 people, 20.00%
Hypolipidaemia (an abnormally high concentration of fats or lipids in the blood): 6 people, 20.00%
Enlarged Prostate: 6 people, 20.00%
Joint Pain: 5 people, 16.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 13.33%
Gastric Disorder (disease of stomach): 2 people, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.33%

Common drugs taken by these people *:

Dupixent: 21 people, 70.00%
Tamsulosin: 6 people, 20.00%
Pantoprazole: 6 people, 20.00%
Aspirin: 4 people, 13.33%
Ibuprofen: 2 people, 6.67%
Tylenol: 2 people, 6.67%
Glimepiride: 1 person, 3.33%
Ambien: 1 person, 3.33%
Amlodipine: 1 person, 3.33%
Azelastine Hydrochloride: 1 person, 3.33%

Common symptoms for these people *:

Itching: 12 people, 40.00%
Fatigue (feeling of tiredness): 11 people, 36.67%
Pain: 9 people, 30.00%
Speech Impairment (Adult) (inability to speak (adult)): 8 people, 26.67%
Nausea And Vomiting: 7 people, 23.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 23.33%
Skin Atrophy (wasting of skin): 7 people, 23.33%
Muscle Aches (muscle pain): 7 people, 23.33%
Confusion: 7 people, 23.33%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 23.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Neurodermatitis (6,283 reports)
Memory loss (244,445 reports)

All the drugs that are associated with Memory loss:

Memory loss (2,726 drugs)

All the conditions that are associated with Memory loss:

Memory loss (4,378 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Neurodermatitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.